Clinical Trials Browser

INDUSTRY × Neoplasms × sepantronium × Clear all

NCT00514267 2015-08-13

An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors

Phase 1/2 Completed

Neoplasms, Prostatic Neoplasms

NCT01023386 2010-04-13

A Clinical Pharmacological Study of YM155 After Intravenous Infusion in Patients With Advanced Cancer

Phase 1 Completed

Neoplasms